Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of “Hold” by Analysts

Shares of Teladoc Health, Inc. (NYSE:TDOC) have received a consensus rating of “Hold” from the eighteen analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and five have assigned a buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $9.60.

Several equities analysts have recently issued reports on TDOC shares. Zacks Research cut Teladoc Health from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 10th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Teladoc Health in a report on Monday. Citigroup boosted their price objective on shares of Teladoc Health from $9.50 to $10.50 and gave the company a “neutral” rating in a research report on Tuesday, October 21st. BMO Capital Markets began coverage on shares of Teladoc Health in a report on Thursday, November 13th. They issued a “market perform” rating and a $8.00 price objective for the company. Finally, Evercore ISI cut their target price on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a research note on Thursday, October 30th.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 5,720 shares of Teladoc Health stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total transaction of $42,842.80. Following the sale, the insider directly owned 80,732 shares of the company’s stock, valued at approximately $604,682.68. The trade was a 6.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Fernando M. Rodrigues sold 4,209 shares of the company’s stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold at an average price of $7.48, for a total value of $31,483.32. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 33,288 shares of company stock valued at $251,684. 0.58% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

A number of institutional investors have recently added to or reduced their stakes in TDOC. Teacher Retirement System of Texas lifted its position in Teladoc Health by 5.7% during the second quarter. Teacher Retirement System of Texas now owns 26,592 shares of the health services provider’s stock valued at $232,000 after buying an additional 1,431 shares during the period. Federated Hermes Inc. grew its position in shares of Teladoc Health by 0.5% in the 3rd quarter. Federated Hermes Inc. now owns 307,700 shares of the health services provider’s stock worth $2,379,000 after buying an additional 1,450 shares during the period. Creative Planning grew its position in shares of Teladoc Health by 7.7% in the 3rd quarter. Creative Planning now owns 20,567 shares of the health services provider’s stock worth $159,000 after buying an additional 1,462 shares during the period. Krane Funds Advisors LLC increased its stake in shares of Teladoc Health by 13.4% in the 3rd quarter. Krane Funds Advisors LLC now owns 12,431 shares of the health services provider’s stock worth $106,000 after acquiring an additional 1,469 shares in the last quarter. Finally, National Bank of Canada FI lifted its position in Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock valued at $28,000 after acquiring an additional 1,581 shares during the period. Institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Performance

Teladoc Health stock opened at $7.23 on Thursday. The company has a current ratio of 2.70, a quick ratio of 2.60 and a debt-to-equity ratio of 0.71. The firm has a market cap of $1.28 billion, a P/E ratio of -5.64 and a beta of 2.04. Teladoc Health has a 1-year low of $6.35 and a 1-year high of $15.21. The firm has a 50-day moving average of $7.86 and a 200-day moving average of $7.80.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.05. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The company had revenue of $626.44 million for the quarter, compared to the consensus estimate of $625.66 million. During the same quarter in the previous year, the business earned ($0.19) EPS. Teladoc Health’s revenue was down 2.2% compared to the same quarter last year. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Sell-side analysts expect that Teladoc Health will post -1.16 EPS for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.